by Institute for Personalized Medicine | Aug 22, 2017 | Bredesen Papers
Abstract To date, no truly effective therapy has been developed for Alzheimer’s disease or mild cognitive impairment. In searching for new approaches that may succeed where previous ones have failed, it may be instructive to consider the successful therapeutic...
by Institute for Personalized Medicine | Aug 22, 2017 | Bredesen Papers
Abstract Alzheimer’s disease is one of the most significant healthcare problems nationally and globally. Recently, the first description of the reversal of cognitive decline in patients with early Alzheimer’s disease or its precursors, MCI (mild cognitive impairment)...
